Quelltext anzeigen

{{up|Target ACE2, Spike protein}}
{{tp|p=32092392|t=2020. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV |pdf=|usr=}}
{{tp|p=32199943|t=ä. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2 |pdf=|usr=}}
{{tp|p=32100877|t=ä. Composition and divergence of coronavirus spike proteins and host ACE2 receptors  predict potential intermediate hosts of SARS?CoV?2 |pdf=|usr=}}
{{tp|p=32249956|t=ä. Structural variations in human ACE2 may influence its binding with SARS?CoV?2 spike protein |pdf=|usr=}}
{{tp|p=32374452|t=2020. SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein |pdf=|usr=}}
{{tp|p=32239522|t=ä. SARS?CoV?2 spike protein favors ACE2 from Bovidae and Cricetidae |pdf=|usr=}}
{{tp|p=32520981|t=2020. ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2.|pdf=|usr=008}}